VP of Investor Relations - Oliver Moravcevic President and Chief Executive Officer - Aziz Mottiwala Chief Financial Officer - Mark Wilterding Operator: Thank you for standing by, and welcome to the RxSight Second Quarter 2026 Earnings Conference. [Operator Instructions] I would now like to turn the conference over to Oliver Moravcevic, VP of Investor Relations. Oliver Moravcevic: Thank you, operator. With me on the call today are RxSight President and Chief Executive Officer, Aziz Mottiwala, and Chief Financial Officer, Mark Wilterding.
Earlier today, RxSight released financial results for the 3 months ended June 30, 2026. A copy of the press release is available now on the company's website. Before we begin, I would like to remind you that comments and responses to questions during today's call reflect management's views as of today and will include forward-looking and opinion statements, including predictions, estimates, plans, and expectations.
Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully described in our press release issued today and in our filings with the Securities and Exchange Commission or SEC. Our SEC filings can be found on our website or the SEC's website.
Investors are cautioned not to place undue reliance on forward-looking statements, and we disclaim any obligation to update or revise these forward-looking statements except as may be required by law. We'll also discuss certain non-GAAP financial measures. Disclosures regarding non-GAAP financial measures, including reconciliations with the most comparable GAAP measures, which can be found in the press release.
Please note that this conference call will be available for audio replay on our Investor Relations website. With that, I will turn the call over to Aziz. Aziz Mottiwala: Thank you, Oliver, and thank you, and good afternoon, everyone.
I'm delighted to be at RxSight and to be speaking with you today. I've spent most of my career in eye care, an area of health care that represents a significant opportunity to make life-changing differences in the quality of patients' lives. Joining a company dedicated to improving people's vision is a tremendous privilege, and in a large part is what attracted me to RxSight.
Extract — continue reading at the source.
